What are the TES/AACC/ESE recommendations for genetic testing in pheochromocytoma and paraganglioma?

Updated: Feb 12, 2019
  • Author: Cameron K Tebbi, MD; Chief Editor: Max J Coppes, MD, PhD, MBA  more...
  • Print

For genetic testing, TES/AACC/ESE recommendations are as follows:

  • Patients with PPGLs should be engaged in shared decision-making for genetic testing

  • Patients with paraganglioma should undergo testing of succinate dehydrogenase (SDH) mutations

  • Patients with metastatic disease should undergo testing for SDHB mutations

  • Genetic testing should include pre- and posttest genetic counseling

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!